- Home
- BLND vs PALI Comparison
BLND vs PALI Comparison
Compare BLND & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLND | PALI |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.6M | 359.7M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BLND | PALI |
|---|---|---|
| Price | $1.77 | $1.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $4.13 | ★ $11.29 |
| AVG Volume (30 Days) | 2.5M | ★ 4.7M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.33 | ★ 97.06 |
| EPS | N/A | N/A |
| Revenue | ★ $123,585,000.00 | $260,000.00 |
| Revenue This Year | $12.62 | N/A |
| Revenue Next Year | $14.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $1.18 | $0.55 |
| 52 Week High | $4.49 | $2.86 |
Technical Indicators
Market Signals| Indicator | BLND | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 45.67 |
| Support Level | $1.56 | $1.57 |
| Resistance Level | $1.87 | $2.16 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 55.77 | 15.69 |
Price Performance
Historical ComparisonAbout BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.